Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2005
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://ncbi.nlm.nih.gov/pubmed/15642147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1457
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk